(DCOR) Dimensional Trust - Overview
Etf: Equity, Diverse, U.S., Broad
Dividends
| Dividend Yield | 1.04% |
| Yield on Cost 5y | 1.46% |
| Yield CAGR 5y | 13.40% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.4% |
| Relative Tail Risk | 2.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 1.39 |
| Character TTM | |
|---|---|
| Beta | 0.932 |
| Beta Downside | 0.953 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.10% |
| CAGR/Max DD | 1.09 |
Description: DCOR Dimensional Trust January 14, 2026
Dimensional ETF Trust’s DCOR ETF aims to meet its investment objective by employing an integrated approach that blends research, portfolio design, active management, and systematic trading. The fund primarily targets a broad, diversified set of U.S. equity securities, committing at least 80 % of net assets to these stocks under its non-fundamental policy.
As of the most recent data (Q4 2025), DCOR carries an expense ratio of 0.12 %, holds roughly $1.3 billion in assets under management, and exhibits an average turnover of 12 % per year-indicative of a relatively low-turnover, cost-efficient strategy. The ETF’s large-blend classification translates to a market-cap weighted exposure of about 55 % to the Information Technology sector and 20 % to Health Care, both of which are sensitive to U.S. corporate earnings growth and Federal Reserve interest-rate policy.
For a deeper dive into the fund’s factor exposures and performance metrics, the ValueRay platform offers a free, interactive toolkit to help you assess whether DCOR aligns with your investment thesis.
What is the price of DCOR shares?
Over the past week, the price has changed by +1.40%, over one month by +1.70%, over three months by +6.77% and over the past year by +15.98%.
Is DCOR a buy, sell or hold?
What are the forecasts/targets for the DCOR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 85.3 | 11.6% |
DCOR Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.56b USD (2.56b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.56b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.56b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.35% (E(2.56b)/V(2.56b) * Re(9.35%) + (debt-free company))
Discount Rate = 9.35% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)